Rigel Pharmaceuticals logo
Rigel Pharmaceuticals RIGL
$ 26.7 -1.28%

Quarterly report 2024-Q3
added 11-07-2024

report update icon

Rigel Pharmaceuticals DPO Ratio 2011-2024 | RIGL

Annual DPO Ratio Rigel Pharmaceuticals

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
761 2.74 K 1.26 K 1.6 K 1.67 K 8.13 K - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
8.13 K 761 2.7 K

Quarterly DPO Ratio Rigel Pharmaceuticals

2024-Q3 2024-Q2 2024-Q1 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
56.5 250 389 476 490 1.35 K - 497 203 3.17 K - 1.46 K 2.4 K 1.27 K - 2.42 K 1.21 K 2.31 K - 1.22 K 1.22 K 4.5 K - 8.45 K 19.4 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
19.4 K 56.5 2.64 K